10th September, 2025, Kolkata: Suraksha Diagnostic Limited (“Suraksha Clinic and Diagnostics”), one of the leading diagnostics chains in Eastern India organised a Genomics and Foetal Health workshop aiming to educate and empower expectant women and their families with accurate, science-based knowledge about the role of foetal medicine and genetic screening in ensuring a healthy pregnancy.
The workshop was led by gynaecologist, and Fetal Medicine Specialist, Dr. Pradip Goswami. The event was also graced by the presence of Ms. Upasana Mukherjee, Consultant Genetic Counselor, BGCI Level II Certified, Medical Geneticist, Clinical Genomics. The workshop highlighted how in every 100 pregnancies, while most babies are born healthy, around 8–10% may have minor or major congenital issues, some of which are linked to non-curable genetic disorders. Genomic technology now makes it possible to detect many of these conditions even before birth by analysing foetal DNA extracted from the mother’s womb. This enables prospective parents to be informed about the child’s genetic health, understand the risks, and make appropriate decisions about the current and future pregnancies. Suraksha Clinic and Diagnostics’ Genomic testing lab can detect chromosomal abnormalities like Down syndrome, Edwards Syndrome, Patau syndrome, as well as sex chromosome aneuploidies. Providing Eastern India’s largest and most advanced genomic testing facilities, Suraksha Clinic and Diagnostics has made considerable contribution in the future of preventive care by enabling early, accurate risk detection and better treatment planning.
Dr Goswami highlighted how in the present time with shrinking family units and limited support systems, it crucial to ensure that both mother and baby are safe and healthy during and after pregnancy. This workshop focused on the growing importance of foetal medicine, and its integration with the rapidly advancing field of genomics. These medical advancements now allow for early diagnosis of congenital and genetic conditions during pregnancy, often as early as the third month. Dr Goswami pointed out by combining foetal medicine and genetic testing under one roof Suraksha Clinic and Diagnostics ensures faster diagnosis, better quality of care, and more personalised guidance for families.
Dr Somnath Chatterjee, Chairman and Joint Managing Director of Suraksha Clinic & Diagnostics, said about the workshop, “At Suraksha Clinic and Diagnostics, we believe that awareness and early intervention are critical to improving maternal and child health outcomes. With advancements in foetal medicine and genomics, we now have the ability to detect and address potential complications before birth. This workshop is a step toward empowering families with the knowledge and access they need to make informed decisions and ensure a safe and healthy pregnancy.”
Ms Ritu Mittal, Joint Managing Director and CEO of Suraksha Clinic & Diagnostics, added, “Through initiatives like this workshop, we aim to strengthen prenatal care by combining clinical expertise with advanced diagnostics, ensuring the best possible outcomes for both mother and child”
The workshop underscores Suraksha Clinic and Diagnostics’ ongoing commitment towards advanced maternal and prenatal care. By bringing genomics and foetal medicine under one platform, it continues to support evidence-based care and informed decision-making for expectant families.
